SCM
LLY icon

Sandler Capital Management’s Eli Lilly LLY Stock Holding History

Sandler Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
2,171
+19
+0.9% +$19.3K 1.03% 29
2025
Q4 		$2.31M Buy
2,152
+211
+11% +$202K 0.76% 49
2025
Q3 		$1.48M Sell
1,941
-885
-31% -$659K 0.44% 84
2025
Q2 		$2.2M Sell
2,826
-5,436
-66% -$4.22M 0.6% 69
2025
Q1 		$6.82M Buy
8,262
+700
+9% +$582K 1.71% 10
2024
Q4 		$5.84M Sell
7,562
-4,295
-36% -$3.56M 0.61% 65
2024
Q3 		$10.5M Buy
11,857
+736
+7% +$662K 1.39% 14
2024
Q2 		$10.1M Buy
11,121
+780
+8% +$624K 1.08% 28
2024
Q1 		$8.04M Sell
10,341
-12,100
-54% -$8.61M 0.59% 68
2023
Q4 		$13.1M Buy
22,441
+2,791
+14% +$1.63M 1.08% 35
2023
Q3 		$10.6M Buy
+19,650
New +$10.1M 1.09% 35

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sandler Capital Management's LLY Position: Q1 2026 in Review

Sandler Capital Management increased its Eli Lilly (LLY) stake by 0.88% in Q1 2026, buying an estimated $19.3K and bringing the position to 2,171 shares worth $2M. The position accounts for 1.03% of the portfolio, ranked #29.

Sandler Capital Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $13.1M in Q4 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sandler Capital Management held 2,171 shares of Eli Lilly worth $2M as of Q1 2026.
  • Sandler Capital Management bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 1.03% of Sandler Capital Management's portfolio in Q1 2026, its #29 holding.
  • Sandler Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Sandler Capital Management's Eli Lilly position peaked at $13.1M in Q4 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.